Stock Chart
LGND
Type: SELL growth_1yr
Strike: $290
Premium: $54.50
Expiry: Jun 17, 2027
Target: $292
Score: -97
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About LGND - Ligand Pharmaceuticals Inc.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Key Statistics
More LGND Analysis
This LGND stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track LGND's price movements with trendlines, gamma walls, and key support/resistance levels.